Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 22, 2021

SELL
$102.33 - $144.73 $45.1 Million - $63.8 Million
-440,802 Closed
0 $0
Q2 2021

Jul 27, 2021

SELL
$113.03 - $155.64 $6.23 Million - $8.57 Million
-55,079 Reduced 11.11%
440,802 $57.8 Million
Q1 2021

Apr 23, 2021

SELL
$99.52 - $215.83 $22 Million - $47.6 Million
-220,559 Reduced 30.79%
495,881 $75.6 Million
Q4 2020

Jan 26, 2021

BUY
$80.55 - $106.05 $567,233 - $746,804
7,042 Added 0.99%
716,440 $71.3 Million
Q3 2020

Oct 23, 2020

BUY
$89.56 - $126.72 $3.28 Million - $4.64 Million
36,630 Added 5.44%
709,398 $67.6 Million
Q2 2020

Aug 03, 2020

BUY
$68.28 - $123.65 $1.65 Million - $2.99 Million
24,165 Added 3.73%
672,768 $75.2 Million
Q1 2020

Apr 17, 2020

BUY
$63.37 - $107.88 $1.83 Million - $3.12 Million
28,950 Added 4.67%
648,603 $47.2 Million
Q4 2019

Jan 24, 2020

SELL
$96.94 - $113.59 $1.26 Million - $1.48 Million
-13,041 Reduced 2.06%
619,653 $64.6 Million
Q3 2019

Oct 25, 2019

SELL
$86.25 - $120.16 $345,431 - $481,240
-4,005 Reduced 0.63%
632,694 $63 Million
Q2 2019

Aug 02, 2019

BUY
$107.38 - $129.34 $1.69 Million - $2.03 Million
15,693 Added 2.53%
636,699 $72.7 Million
Q1 2019

Apr 18, 2019

BUY
$105.93 - $142.47 $14.2 Million - $19.1 Million
134,173 Added 27.56%
621,006 $78.1 Million
Q4 2018

Jan 28, 2019

SELL
$128.36 - $272.13 $10.2 Million - $21.6 Million
-79,390 Reduced 14.02%
486,833 $66.1 Million
Q3 2018

Oct 25, 2018

BUY
$211.18 - $274.49 $13.6 Million - $17.7 Million
64,329 Added 12.82%
566,223 $155 Million
Q2 2018

Jul 20, 2018

BUY
$150.77 - $207.98 $4.73 Million - $6.52 Million
31,364 Added 6.67%
501,894 $104 Million
Q1 2018

Apr 24, 2018

SELL
$138.63 - $182.62 $2.68 Million - $3.52 Million
-19,300 Reduced 3.94%
470,530 $77.7 Million
Q4 2017

Jan 22, 2018

BUY
$128.36 - $147.04 $7.28 Million - $8.34 Million
56,705 Added 13.09%
489,830 $67.1 Million
Q3 2017

Oct 20, 2017

BUY
$120.91 - $137.94 $52.4 Million - $59.7 Million
433,125
433,125 $59 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.91B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Conestoga Capital Advisors, LLC Portfolio

Follow Conestoga Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Conestoga Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Conestoga Capital Advisors, LLC with notifications on news.